Contribute Try STAT+ Today

Advances in the life sciences over the past decade have made it possible to manipulate genetic codes on the molecular level. Devices can see inside the human body with a level of precision that seemed unfathomable just a few years ago. And in a matter of months, researchers have created a multitude of vaccines for the novel coronavirus that has devastated the world.

Yet despite many amazing advancements, the artificial intelligence (AI) platforms that help enable many of these triumphs continue to show astonishing levels of bias.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.